• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ALA 0.00% 12.5¢

AROVELLA THERAPEUTICS LIMITED

Arovella Therapeutics Limited is a biotechnology company. The Company is focused on... Arovella Therapeutics Limited is a biotechnology company. The Company is focused on developing its invariant natural killer T (iNKT) cell therapy platform from Imperial College London to treat blood cancers and solid tumors. The Company's lead product is ALA-101. ALA-101 is being developed as an allogeneic cell therapy, which means it can be given from a healthy donor to a patient. ALA-101 is a next-generation CAR-iNKT cell therapy that targets CD19+ B cell lymphomas and leukemias. ALA-101 consists of CAR19-iNKT cells that have been modified to produce a Chimeric Antigen Receptor (CAR) that targets CD19. CD19 is an antigen found on the surface of numerous cancer types. The Company is also engaged in expanding solid tumor treatment through its CLDN18.2-targeting technology licensed from Sparx Group. Its iNKT cells also contain an invariant T cell receptor (iTCR) that targets alpha-galactosylceramide (a-GalCer) bound CD1d, another antigen found on the surface of several cancer types.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
ALA 01/05/24 0 417
01/05/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  417 
ALA 30/04/24 2 1.1K
30/04/24 Last post  Bluebush Comments Created with Sketch.  2  Views Created with Sketch.  1.1K 
ALA
Breakout Looming?
4 5 6
29/04/24 351 154K
TRENDING NEWS

What does it take to get a new drug to market in Australia?

NEWS
09 May 2024
29/04/24 Last post  portsea7 Comments Created with Sketch.  351  Views Created with Sketch.  154K 
ALA 26/04/24 3 1.5K
26/04/24 Last post  abitlikeme Comments Created with Sketch.  3  Views Created with Sketch.  1.5K 
ALA 23/04/24 0 303
23/04/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  303 
ALA 23/04/24 62 27K
23/04/24 Last post  Uttsy Comments Created with Sketch.  62  Views Created with Sketch.  27K 
ALA
Latest technical for ALA - Arovella Therapeutics: Chart Inside
12/04/24 0 425
12/04/24 Last post  TheUnit Comments Created with Sketch.  0  Views Created with Sketch.  425 
ALA 14:15 1 524
14:15 Last post  abitlikeme Comments Created with Sketch.  1  Views Created with Sketch.  524 

See All Discussions arrow Created with Sketch.

Timeline

Updated Share Trading Policy
01 May 11:38
 
Quarterly Activities/Appendix 4C Cash Flow Report
30 Apr 09:51
 
Proposed issue of securities - ALA
23 Apr 13:41
 
Notice of Extraordinary General Meeting/Proxy Form
23 Apr 13:26
 
Notification regarding unquoted securities - ALA
10 Apr 13:51
 
Arovella presents ALA-101 data at AACR
09 Apr 08:56
 
View More arrow Created with Sketch.
(20min delay)
Last
12.5¢
Change
0.000(0.00%)
Mkt cap ! $131.2M
Open High Low Value Volume
12.5¢ 12.5¢ 12.0¢ $130.6K 1.049M

Buyers (Bids)

No. Vol. Price($)
11 494725 12.0¢
 

Sellers (Offers)

Price($) Vol. No.
12.5¢ 29845 6
View Market Depth
Last trade - 16.10pm 09/05/2024 (20 minute delay) ?
Last
12.5¢
  Change
0.000 ( 4.17 %)
Open High Low Volume
12.5¢ 12.5¢ 12.0¢ 528422
Last updated 15.22pm 09/05/2024 ?
ALA (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.